[Skip to Navigation]
Sign In

Year

Day

May 19, 2022
Viewpoint

Antiabortion Laws and Implications for Patients With Cardiovascular Disease in Pregnancy

Abstract Full Text
JAMA Cardiol. Published online May 19, 2022. doi:10.1001/jamacardio.2022.1665

This Viewpoint discusses the effect of antiabortion legislation on the health of patients with cardiovascular disease in pregnancy.

May 18, 2022
Original Investigation

Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations

Abstract Full Text
JAMA Cardiol. Published online May 18, 2022. doi:10.1001/jamacardio.2022.0912

This cohort study investigates the association between very high high-density lipoprotein cholesterol (HDL-C) level and outcomes in patients with coronary artery disease.

Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National Biobank

Abstract Full Text
JAMA Cardiol. Published online May 18, 2022. doi:10.1001/jamacardio.2022.1061

This cohort study examines data from the UK Biobank and Mass General Brigham Biobank to assess the contribution of rare and common genetic variants to risk of hypertrophic cardiomyopathy in the general population.

Review

Lipoprotein(a) and its Significance in Cardiovascular Disease: A Review

Abstract Full Text
has active quiz
JAMA Cardiol. Published online May 18, 2022. doi:10.1001/jamacardio.2022.0987

This narrative review evaluates evidence of an association between elevated lipoprotein(a) levels, atherosclerotic cardiovascular disease, and aortic valve stenosis.

Comment & Response

The “Power of Zero” in Younger Patients—A Glass Half Empty or a Glass Half Full?

Abstract Full Text
JAMA Cardiol. Published online May 18, 2022. doi:10.1001/jamacardio.2022.0978

The “Power of Zero” in Younger Patients—A Glass Half Empty or a Glass Half Full?—Reply

Abstract Full Text
JAMA Cardiol. Published online May 18, 2022. doi:10.1001/jamacardio.2022.0981
Editor's Note

Very Elevated High-Density Lipoprotein Cholesterol and Mortality—The Good Gone Bad?

Abstract Full Text
JAMA Cardiol. Published online May 18, 2022. doi:10.1001/jamacardio.2022.0924
May 11, 2022
Original Investigation

Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes

Abstract Full Text
open access has audio
JAMA Cardiol. Published online May 11, 2022. doi:10.1001/jamacardio.2022.0810

This cohort study assesses the association of rare variants of cardiomyopathy and arrhythmia genes with all-cause mortality among patients with early-onset atrial fibrillation.

Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes and All-Cause Mortality

Abstract Full Text
has audio
JAMA Cardiol. Published online May 11, 2022. doi:10.1001/jamacardio.2022.0901

This genetic association study investigates the association of pathogenic DNA variants implicated in inherited cardiomyopathy with cardiovascular disease outcomes and all-cause mortality.

Viewpoint

Athletes With Cardiovascular Disease and Competitive Sports Eligibility: Progress and Challenges Ahead

Abstract Full Text
JAMA Cardiol. Published online May 11, 2022. doi:10.1001/jamacardio.2022.0806

This Viewpoint discusses patient centered shared-decision making for athletes with heart disease.

Editorial

Genetic Testing for Early-Onset Atrial Fibrillation—Is It Time to Personalize Care?

Abstract Full Text
JAMA Cardiol. Published online May 11, 2022. doi:10.1001/jamacardio.2022.0909
May 4, 2022
Original Investigation

Trends in 10-Year Outcomes Among Medicare Beneficiaries Who Survived an Acute Myocardial Infarction

Abstract Full Text
JAMA Cardiol. Published online May 4, 2022. doi:10.1001/jamacardio.2022.0662

This cohort study evaluates trends in 10-year all-cause mortality and hospitalization for recurrent acute myocardial infarction by demographic subgroups and examines the association between recurrence and mortality.

Long-term Survival After Out-of-Hospital Cardiac Arrest: A Systematic Review and Meta-analysis

Abstract Full Text
JAMA Cardiol. Published online May 4, 2022. doi:10.1001/jamacardio.2022.0795

This meta-analysis of patients with out-of-hospital cardiac arrest assesses the long-term survival rate in those who survive the initial hospital stay.

Research Letter

Trends in Transcatheter vs Surgical Mitral Valve Repair Among Medicare Beneficiaries, 2012 to 2019

Abstract Full Text
JAMA Cardiol. Published online May 4, 2022. doi:10.1001/jamacardio.2022.0775

This cross-sectional study of Medicare data from 2012 to 2019 assesses national trends in the use of mitral transcatheter edge-to-edge repair relative to surgical mitral valve repair.

Invited Commentary

Treatment of Out-of-Hospital Cardiac Arrest

Abstract Full Text
JAMA Cardiol. Published online May 4, 2022. doi:10.1001/jamacardio.2022.0803
Comment & Response

Could Neprilysin Be Already Inhibited by BNP in the LIFE Trial?

Abstract Full Text
JAMA Cardiol. Published online May 4, 2022. doi:10.1001/jamacardio.2022.0784

Could Neprilysin Be Already Inhibited by BNP in the LIFE Trial?—Reply

Abstract Full Text
JAMA Cardiol. Published online May 4, 2022. doi:10.1001/jamacardio.2022.0787
×